Generic drugmaker Teva names Frost as chairman
(AP)
AP - Generic drugmaker Teva Pharmaceutical Industries Ltd. said Tuesday it has appointed vice chairman Dr. Phillip Frost to serve as chairman of its board.
Mass. father casts blame in daughter's drug death
(AP)
AP - The Massachusetts man accused of killing his 4-year-old daughter by overmedicating her with prescription drugs is blaming his wife and a psychiatrist for the girl's death in 2006.
Franchisees suing Cardinal Health over agreements
(AP)
AP - Medicine Shoppe and Medicap pharmacists in seven states sued Cardinal Health in federal court Tuesday, alleging the health care products distributor failed to make good on promises it made when it asked them to switch to a new franchise agreement.
AP - Two of the world's biggest pharmaceutical companies said Tuesday they are uniting their animal health businesses in a deal to become the top dog in the veterinary industry.
AFP - French pharmaceutical giant Sanofi-Aventis and US group Merck announced on Tuesday they would join forces to create the world's biggest animal health company.
WuXi PharmaTech moves to 4th-quarter profit
(AP)
AP - WuXi PharmaTech Inc. late Monday said it shifted to a profit in the fourth quarter, compared with a year-ago period when the research and development outsourcing company lost money due to a large impairment charge.
Merck, Sanofi to unite animal medicine businesses
(AP)
AP - PET MEDS: Two top pharmaceutical companies, Merck & Co. and Sanofi-Aventis SA, are uniting their animal health businesses in what would be the world's largest veterinary medicine company.
Tenn. federal judge won't dismiss jaw injury cases
(AP)
AP - A federal judge in Nashville has refused to dismiss 40 lawsuits against a Swedish-based pharmaceutical company accused of failing to warn patients that two of its drugs can cause severe deterioration of the jaw.
ImmunoGen cancer drug gets 'orphan drug' status
(AP)
AP - ImmunoGen Inc. said Monday the Food and Drug Administration and European regulators gave the company's potential cancer drug IMGN901 "orphan drug" status.
Acura, King cite positive study on pain drug
(AP)
AP - Acura Pharmaceuticals Inc. and King Pharmaceuticals Inc. said Monday the potential abuse-resistant painkiller Acurox met key goals in a pivotal study.
ISTA says FDA to review eye drug by Oct. 16
(AP)
AP - ISTA Pharmaceuticals Inc. said Monday the Food and Drug Administration will make a regulatory decision on the once-daily eye inflammation treatment XiDay by Oct. 16.
Roche suspends arthritis drug study after deaths
(AP)
AP - Swiss pharmaceutical company Roche Group said Monday it has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from infections.
Astra's colon cancer drug fails test
(AP)
AP - AstraZeneca PLC said Monday that its cancer drug Recentin failed in a head to head late stage trial with Roche AG's Avastin in tests for use as an initial treatment against colon cancer.
Drugmakers boost consumer ad spending 2 pct in '09
(AP)
AP - Pharmaceutical companies boosted their spending on ads directly targeting consumers by barely 2 percent last year, according to data compiled by The Nielsen Co.
Takeda renames heartburn drug to avoid errors
(AP)
AP - Federal regulators said Thursday that Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.
Inspire posts smaller loss as Azasite sales rise
(AP)
AP - Inspire Pharmaceuticals Inc. said Thursday it had a smaller loss in the fourth quarter, as sales of its pinkeye treatment Azasite climbed due to a shortage of a competing product.
Jazz reports 4Q profit on Xyrem sales boost
(AP)
AP - Jazz Pharmaceuticals Inc. reported a fourth-quarter profit on Wednesday on lower costs and a boost in sales from the sleep disorder treatment Xyrem.
Reuters - U.S. stocks ended little changed on Wednesday as worries about bank regulation and a setback for drug company Pfizer offset signs of improvement in the labor market and services sector.
Hot News